US Pharmaceuticals Recalls Adult Glycerin Suppositories for Water Quality Issues
US Pharmaceuticals is recalling 880 cases of Adult Glycerin Suppositories because purified water used in manufacturing failed quality tests for microbial count or organic carbon.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a manufacturing deviation (water quality) without reported illnesses, fitting the Moderate category for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
US Pharmaceuticals Inc. is recalling 880 cases of Adult Glycerin Suppositories (NDC#0363-0441-00). The product is distributed by Walgreen Co. and was available nationwide in the United States. The recall involves specific lots with expiration dates of 07/2019 and 11/2019.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, out-of-specification results were found for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Consumers who have these products should stop using them and return them to the point of purchase or contact the recalling firm for instructions. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- Adult Glycerin Suppositories, Package Size 100-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0441-00
- Manufacturer
- US Pharmaceuticals Inc.
- Category
- Drug — Suppositories
- Affected units
- 880
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #'s 68J17
- 71J17
- 72J17
- 73J17
- 77J17
- 78J17
- 79J17
- 81J17
- 82J17 - EXP 07/2019
- 27P17
- 28P17
- 29P17
- 30P17
- 31P17
- 32P17
- 33P17
- 37P17
- 38P17
- EXP 11/2019.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by US Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · US Pharmaceuticals Inc.
See all →- ModerateCVS Healing Ointment Recalled for Low Weight Fill Tubes
FDA (Drugs) · 2020-12-09
- ModerateUS Pharmaceuticals Recalls Intensive Healing Eczema Lotion for Water Quality Issues
FDA (Drugs) · 2019-08-21
- ModerateCVS Health Glycerin Suppositories Recalled for Water Quality Issues
FDA (Drugs) · 2019-08-21
- ModerateUS Pharmaceuticals Recalls Soothe&Cool Protect Moisture Guard Skin Protectant
FDA (Drugs) · 2019-08-21
- ModerateUS Pharmaceuticals Recalls Adult Glycerin Suppositories Due to Water Quality Issues
FDA (Drugs) · 2019-08-21
Same hazard · contamination
See all →- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- ModerateAVID Medical Recalls 15 Laparoscopic Prostatectomy Kits for Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls 23 ABD Hysterectomy Kits Due to Lubricant Contamination
FDA (Devices) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- ModerateAVID Medical Recalls GYN Laparoscopy Kits for Potential Lubricant Contamination
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateUS Pharmaceuticals Recalls Hydrocortisone Cream Due to Microbial Contamination
FDA (Drugs) · 2019-02-13
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- SevereAdvanced Compounding Pharmacy Recalls Glycerin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- ModerateAmerican Pharmaceutical Ingredients Recalls Gabapentin USP for Prescription Compounding
FDA (Drugs) · 2018-02-28
- SevereAurobindo Recalls Gabapentin Capsules Due to Manufacturing Water Leakage
FDA (Drugs) · 2020-04-22
- LowGlenmark Recalls Gabapentin Tablets Due to Chemical Contamination and Off-Odor
FDA (Drugs) · 2013-05-22